Search results

107 items
  1. Europe and US split over drugs policy at UN

    Tom Blickman
    30 January 2009
    Article

    The fight over the introduction of harm reduction in the Political Declaration of the UNGASS review has now reached the newspapers. A report by Reuters said that the 'US and Europe split over drugs policy'. "US negotiators are trying to push through anti-drug programmes that were promoted during the former Bush administration but which are no longer advocated by President Barack Obama," participants at the talks in Vienna told Reuters.

  2. Image of UN Flag

    The Battle for Harm Reduction

    Tom Blickman
    21 January 2009
    Article

    The issue of harm reduction continues to be controversial during the negotiations in Vienna for the Political Declaration that has to be adopted in March 2009 at the High Level Segment of the Commission on Narcotic Drugs (CND). There is severe pressure on delegates to drop their insistence on incorporating the language and principles of harm reduction in the political declaration, or to accept some watered down version.

  3. Are the three drug conventions still the cornerstone of the world drug control system?

    Katherine Irene Pettus
    20 January 2014
    Other news

    UN member states are currently in the process of hammering out a ‘Joint Ministerial Statement’ for the upcoming High Level Review of the world drug response – at the Commission on Narcotic Drugs (CND) in March. At the most recent ‘inter-sessional meeting’, exasperated delegates of all ideological persuasions repeated variations of the refrain “we’ve already done this…this language is in the Political Declaration…we debated this last year…this paragraph was already settled by consensus.”

  4. WMA warns against making essential anaesthetic a controlled drug

    06 March 2015
    Other news

    Scheduling ketamine would restrict its availability worldwide, which  would lead to harmful impact on animal health and welfare, as well on public health. The World Medical Association is urging its 111 member associations to lobby their governments to oppose scheduling the anaesthetic agent Ketamine as a controlled drug.

  5. cnd

    International AIDS Society calls for Harm Reduction

    25 February 2008
    Article

    25 February 2009

    The International AIDS Society (IAS) wrote a letter to the Chair of the Commission on Narcotics Drugs (CND) to express concern about the absence of language on harm reduction in the draft outcome documents to be adopted by the 52nd session of the Commission on Narcotic Drugs in March 2009.

    The International AIDS Society is world’s leading independent association of HIV professionals with over 11,000 members from 183 countries; and the custodian of the International AIDS Conference to be held in Vienna in 2010.

  6. cnd2013

    CND informal consensus rule tested in decriminalization standoff

    04 November 2013
    In the media

    Country delegations to the UN Commission on Narcotic Drugs (CND) don’t usually vote on things… The protocol is that member states reach consensus on language and policy (often meaning that the final language reflects the lowest common denominator). Usually this diplomatic process works and delegates compromise. However, at the most recent inter-sessional meeting of the CND on 5th November, some delegates drew “red lines” and staked out non-negotiable positions on key issues.

  7. International Support for Harm Reduction

    20 January 2009

    A useful overview of UN endorsement of harm reduction measures; the legality of harm reduction services under the Drug Conventions; the obligation in human rights law to ensure access to harm reduction services and the global state of harm reduction, listing 82 countries and territories worldwide that presently support or tolerate harm reduction.

     

  8. Lifting the Ban on Harm Reduction

    Tom Blickman
    21 January 2009
    Article

    The Obama White House announced today that the new President supports lifting the federal ban on needle exchange, which could dramatically reduce rates of HIV/AIDS infection among drug users. Will he also lift the ban on the concept of harm reduction, which has paralysed the international drug policy debate under his predecessors?

  9. US Harm Reduction Coalition calls for change

    Tom Blickman
    27 January 2009
    Article

    Allan Clear of the Harm Reduction Coalition made an urgent appeal on the Obama White House to intervene in the current negotiations about the Political Declaration on the 1998 UNGASS review that has to be adopted in March 2009 at the High Level Segment of the Commission on Narcotic Drugs (CND). For more than two million people living with HIV, mainly in Africa, hopes are high for a change in Obama's foreign policy.

  10. European Cannabis Policies Under Attack

    • Tom Blickman
    01 April 2002
    Policy briefing

    A strong attack against the European practice of 'leniency' regarding cannabis use and possession took place at the United Nations Commission on Narcotic Drugs (CND) session (11-15 March, 2002) in Vienna. There was an orchestrated attempt to pass a CND resolution to put a dam against the 'leniency'.

  11. Cannabis resolutions at the 2008 CND

    29 March 2008

    At the Commission on Narcotic Drugs (CND) in March 2008 in Vienna three resolutions on cannabis were tabled. They were all clearly against 'lenient policies'  in some countries depenalising or decriminalizing the use of cannabis. One of the resolutions called for the criminalization of drug abuse that would have significantly expanded the UN drug conven­tions. 

  12. Image of UN Flag

    Global Fund supports Harm Reduction

    Tom Blickman
    09 February 2009
    Article

    The Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Michel Kazatchkine, urged the president of the UN Commission on Narcotic Drugs (CND) to send a strong message to the world with clear and specific language that calls for comprehensive harm reduction services.

  13. Harm reduction as part of the solution

    Tom Blickman
    23 January 2009
    Article

    It is still not clear what the drug policy of President Obama will be. He has not appointed his drug czar. Many high-ranking Bush Administration officials have yet to leave office and are still setting the agenda on drug policy.
     

  14. Stop US Delegation in Vienna

    Tom Blickman
    29 January 2009
    Article

    The US delegation in Vienna continues to block any inclusion of harm reduction in the new Political Declaration – to be approved in March 2009 at the high-level segment of the 52nd session of the Commission on Narcotic Drugs. Three members of the US Congress have written a letter to the new US Ambassador to the UN, Susan Rice, to call for new instructions to be given to the delegation.

  15. CND decision to schedule ketamine would undermine WHO treaty mandate

    Martin Jelsma
    16 February 2015
    Article

    The UN Commission considers to bring ketamine under the control of the 1971 Convention on Psychotropic Substances contrary to WHO recommendations. The 58th Session of the UN Commission on Narcotic Drugs (CND) in March 2015 has been asked to consider a Chinese proposal to place ketamine – an essential medicine used for anaesthesia – in Schedule I of the 1971 Convention (E/CN.7/2015/7 and E/CN.7/2015/81). Ketamine is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine under any of the 1971 treaty schedules will reduce its availability and further deepen the already acute crisis of global surgery.

  16. The UNGASS outcome document: Diplomacy or denialism?

    14 March 2016
    Declaration

    Drug policy experts and impacted communities from around the world express serious concerns about the preparations and already-drafted outcomes for the UN General Assembly Special Session (UNGASS) on the “world drug problem”.

  17. Image of UN Flag

    A Russian Drug Czar for the world?

    Tom Blickman
    06 July 2010
    Article

    A top Russian diplomat, Yuri V. Fedotov, has emerged as the front-runner in the race to become the Executive Director of the UN Office on Drugs and Crime (UNODC) – the world's new drug czar, according to Colum Lynch, a longtime Washington Post correspondent who reports on the United Nations for Turtle Bay.

  18. Civil Society Statement on Cannabis in Morocco at the Commission on Narcotic Drugs

    21 October 2017
    Article

    The following statement by Abdellatif Adebibe of the Moroccan Confederation of Associations for the Development of the Senhaja Rif Region, was due to be screened as a civil society contribution to a discussion on alternative development and development-oriented drug policy at an intersessional meeting of the Commission on Narcotic Drugs in Vienna. Abdellatif represented cannabis farmers at UNGASS 2016, following the meeting of the Global Forum of Producers of Prohibited Plants in Heemskerk, the Netherlands, organised by TNI.

  19. Global Illicit Drug Markets 1998-2007

    • Peter Reuter (RAND), Franz Trautmann (Trimbos Institute) (eds.)
    15 March 2009
    Report

    This report commissioned by the European Commission, found no evidence that the global drug problem has been reduced during the period from 1998 to 2007 – the primary target of the 1998 UNGASS, which aimed to significantly reduce the global illicit drugs problem by 2008 through international cooperation and measures in the field of drug supply and drug demand reduction. Broadly speaking the situation has improved a little in some of the richer countries, while for others it worsened, and for some of those it worsened sharply and substantially', among which are a few large developing or transitional countries. Given the limitations of the data, a fair judgment is that the problem became somewhat more severe.

  20. UNGASS 2016: Watershed event or wasted opportunity?

    Martin Jelsma
    12 April 2016
    Article

    The outcome of the UN Commission on Narcotic Drugs (CND) was a disappointing compromise, based on a non-inclusive process and one that fails to reflect the fractured global consensus on drug policy.

Pages